# eGVHD vs HemeOncBuddy

The clearest difference is ratings volume: HemeOncBuddy at 18 against eGVHD's 2. eGVHD's advantage is iOS requirement (9.0 vs 15.0). On price, rating, update cadence and ads there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

On the App Store both sit at effectively the same score — 5.0 for eGVHD against 5.0 for HemeOncBuddy. That said, the two scores are not equally well evidenced: HemeOncBuddy has 18 ratings behind it against 2, so its average is the more settled of the two.

eGVHD ships an update every 16 months, HemeOncBuddy every 24 months. The most recent releases landed on September 16, 2026 and October 24, 2026 respectively.

## The numbers

| Metric | eGVHD | HemeOncBuddy |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [5.0 (2 ratings)](https://appshunter.io/ios/app/egvhd/id1355873791/reviews) | [5.0 (18 ratings)](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336/reviews) |
| Number of ratings | 2 | **18** |
| Positive reviews | — | 100.0% of reviews |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | **Every 16 months** | Every 24 months |
| Monetization | Free | Free |
| Size | 81 MB | 16 MB |
| Requires iOS | **9.0** | 15.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 17+ | 17+ |
| Developer | [nexuzhealth NV](https://appshunter.io/developer/1311365149) | [Veli Bakalov](https://appshunter.io/developer/1579207338) |

## What reviewers say

### eGVHD

[App page](https://appshunter.io/ios/app/egvhd/id1355873791)

This educational tool assists healthcare professionals in assessing and scoring the severity of graft versus host disease (GVHD) in allogeneic stem cell transplantation recipients. It uses an algorithm-driven approach to apply internationally recognized criteria, providing differential information and automatic summaries to aid diagnosis.

**Highlights:** Algorithm-driven assessment, GVHD severity scoring, Differential information display, Automatic summary generation, Educational tool for clinicians

**Features:** macOS Compatibility

**In-app purchases:** none


### HemeOncBuddy

[App page](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336)

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

**Highlights:** Practice-changing clinical trial summaries, Hematology and Oncology focus, Simplified trial information, Inclusion and exclusion criteria, Primary endpoints and outcomes, Quick reference tool

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is eGVHD free?

eGVHD is free to download, with no in-app purchases.

### Is HemeOncBuddy free?

HemeOncBuddy is free to download, with no in-app purchases.

### Which has better reviews, eGVHD or HemeOncBuddy?

eGVHD and HemeOncBuddy are both rated 5.0 out of 5 on the App Store, from 2 and 18 ratings respectively.

### Do eGVHD or HemeOncBuddy have ads?

Neither eGVHD nor HemeOncBuddy shows ads.

### Which is updated more often, eGVHD or HemeOncBuddy?

eGVHD ships an update every 16 months, and HemeOncBuddy every 24 months. Most recently, eGVHD was updated on September 16, 2026 and HemeOncBuddy on October 24, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*